Article R5121-76-12 of the French Public Health Code
On receipt of the opinion of the Agence nationale de sécurité du médicament et des produits de santé or on expiry of the period provided for in II of Article R. 5121-76-11, the Minister for Defence may grant the authorisation for use provided for in Article R. 5121-76-10.